SCHEMBL7147906

SCHEMBL7147906

CC(C)Oc1cc(-c2ccco2)nc(N)n1

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
HSD17B10 Q99714 1/20 0.43
ADORA2A P29274 12/20 0.43
ADORA1 P30542 11/20 0.43
ADORA2B P29275 8/20 0.42
ADORA3 P0DMS8 7/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
BLM P54132 1/20 0.42
PTGS1 P23219 1/20 0.40
TPH1 P17752 1/20 0.40
TPH2 Q8IWU9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30353576 0.84 ALDH1A1 (0.58) MAPTHSD17B10ADORA2AADORA1ADORA2B
SCHEMBL1554000 0.79 MAPT (0.58) MAPTHSD17B10ADORA2AADORA1ADORA2B
SCHEMBL29044796 0.78 MAPT (0.53) MAPTHSD17B10ADORA2AADORA1ADORA2B
SCHEMBL30488014 0.78 MAPT (0.53) MAPTHSD17B10ADORA2AADORA1ADORA2B
SCHEMBL30579455 0.76 NPC1 (0.69) MAPTHSD17B10ADORA2AADORA1KDM4E
SCHEMBL30353595 0.75 ADORA2A (0.50) MAPTHSD17B10ADORA2AADORA1ADORA2B
SCHEMBL7147989 0.74 NUDT1 (0.53) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL6828247 0.74 NUDT1 (0.44) MAPTALDH1A1
SCHEMBL7147072 0.73 CCNA2 (0.45) MAPTHSD17B10ADORA2AADORA1ADORA2B
SCHEMBL718474 0.72 HSP90AA1 (0.54) MAPTHSD17B10ADORA2AADORA1ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586441-B2 2-Amino-6-benzylsulfanyl-4-thiophen-2-yl-pyridine-3,5-dicarbo -nitrile as an examplary preferred compound; Alzheimer's and Parkinson's diseases; neuroprotectors; schizophrenia, analgesics; anxiolytic agents; respiratory disorders HOFFMAN-LA ROCHE INC. 2003-07-01 US disclosed